An interventional study of Probiotic, Prebiotic, Polyphenol-rich Extracts and Probiotic, Prebiotic in IBS - Irritable Bowel Syndrome, sponsored by AronPharma Sp. z o. o.. Recruiting at 1 site in Poland. Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2023-11-18.
Sponsored by AronPharma Sp. z o. o. · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies testing probiotic in Irritable Bowel Syndrome — 2 open to participants now, 3 under way, none of them phase 3. Probiotic · Irritable Bowel Syndrome.
Among the 16 studies testing probiotic in Irritable Bowel Syndrome, this one is the 10th largest by planned enrollment, is one of 4 that started in 2023, is one of 10 with no phase, and was the 13th registered.
1,121 studies on the registry are indexed under Irritable Bowel Syndrome; 212 are open to participants now.
Browse Irritable Bowel Syndrome studies →2 of the 16 studies testing probiotic in Irritable Bowel Syndrome are open now, in 2 countries. Recruiting first, the newest first:
University of Bari · Sites in Italy
Ages 4–18
By country, each count listing its studies:
No approval found in the FDA or EMA files read. How studies give it is on its page →
Of the 131 Irritable Bowel Syndrome studies recruiting now, 35 (27%) set no upper age limit and 86 (66%) stop at 75 or younger; 19 take children under 18; 29 take healthy volunteers.
This study: 18 Years to 55 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 4 · Phase 3 1 · Phase 4 1
First in 2007; this study’s year is marked. 4 started in 2023.
This study's planned enrollment of 48 is below the median of 70 across 900 interventional studies indexed under Irritable Bowel Syndrome.
Median enrollment 93 across the 16 interventional studies. Of the 11 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 16 have an industry lead sponsor. The 10 most frequent:
AronPharma Sp. z o. o. is the lead sponsor of 9 studies on the registry; 4 are open to participants now.
AronPharma Sp. z o. o. has 1 study filed under Irritable Bowel Syndrome — fewer than ten, so there is no comparison to draw.
2 of the studies testing probiotic in Irritable Bowel Syndrome that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06317441Nimble Science Ltd.The Safety And Efficacy Of A Probiotic Intervention On Lactulose Hydrogen Breath Test-Positive Patients And Related Gastrointestinal Symptoms | 2027-04 |
| NCT07125625University of BariProbiotic Mixture (L. Rhamnosus GG and L. Plantarum 299V) In Pediatric Irritable Bowel Syndrome | 2027-06-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 16 studies testing probiotic in Irritable Bowel Syndrome, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of the study is to demonstrate a beneficial effect in reducing symptoms that negatively affect the quality of life of IBS patients, and to demonstrate a positive effect on inflammatory and intestinal function markers.
The double-blind, randomized, placebo-controlled study will be conducted on 48 patients (18-55 years old) with Irritable Bowel Syndrome (IBS). The study will consist of 2 months of supplementation with three parallel arms: 1) probiotic strains and prebiotic (Partially Hydrolyzed Guar Gum); 2) probiotic strains, prebiotic (Partially Hydrolyzed Guar Gum) and elderberry and chokeberry fruit extract; 3) placebo.The study will assess symptoms associated with IBS, using the IBS-QOL questionnaire and the Bristol Stool Formation Scale. Markers of inflammation and intestinal barrier permeability , will be determined in blood and stool samples collected from patients.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Autoimmune disease
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
18 patients with IBS
Dietary Supplement: Probiotic, Prebiotic, Polyphenol-rich Extracts
18 patients with IBS
Dietary Supplement: Probiotic, Prebiotic
18 patients with IBS
Other: Placebo
probiotic strains, prebiotic (Partially Hydrolyzed Guar Gum) and elderberry and chokeberry extract Once a day
Drug pages: ProbioticStudies of ProbioticProbiotic pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record. · PrebioticsStudies of PrebioticsPrebiotics pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.
probiotic strains, prebiotic (Partially Hydrolyzed Guar Gum) Once a day
placebo Once a day
IBS-QoL (Irritable Bowel Syndrome-Quality of Life) index
IBS-QoL measures the impact of the disease on the quality of life of patients with IBS
Time frame: Baseline, 2 months
Stool consistency
Will be assessed using the Bristol Stool Chart
Time frame: Baseline, 2 months
Zonulin
Zonulin level in stool samples
Time frame: Baseline, 2 months
Short-chain fatty acids
Short-chain fatty acids level in stool samples
Time frame: Baseline, 2 months
IL-6
IL-6 level in serum samples
Time frame: Baseline, 2 months
IL-8
IL-8 level in serum samples
Time frame: Baseline, 2 months
I-FABP
I-FABP level in serum samples
Time frame: Baseline, 2 months
Plan to share: No
No publications or documents are linked to this record.
Started May 2023 (actual). Primary completion is estimated for Jan 2024, 8 months after the start.
Of 52 industry-sponsored interventional studies with no phase under Irritable Bowel Syndrome, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 28. This study's planned 8 months is below that.
Counting every sponsor, half of 360 studies reached it within 19 months; a quarter within 9 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Probiotic · Prebiotics
AronPharma Sp. z o. o.